Back

Bleeding risk should guide antithrombotic treatment after percutaneous coronary intervention: a Copernican revolution

European Heart Journal

28 August 2024
Organised by: Logo
Read full article
ESC Journals CORONARY ARTERY DISEASE, ACUTE CORONARY SYNDROMES, ACUTE CARDIAC CARE Acute Coronary Syndromes Interventional Cardiology

Contributors

Marco Valgimigli
Marco Valgimigli

Author

Cardiocentro Ticino Institute Lugano , Switzerland

Antonio Landi
Antonio Landi

Author

Cardiocentro Ticino Institute Lugano , Switzerland

You may be interested in
thumbnail
Congress Session
Dual antiplatelet therapy titration after percutaneous coronary intervention: when to escalate, de-escalate, withdraw, and more
28 August 2023
thumbnail
Congress Presentation
Ticagrelor or prasugrel in patients with acute coronary syndrome and high bleeding risk
27 August 2022
thumbnail
Congress Presentation
High bleeding risk mainly predicts non-access site bleeding events in the first month after percutaneous coronary intervention
26 August 2023
thumbnail
Congress Presentation
Perioperative risk and benefit of antiplatelet therapy in patients undergoing non-cardiac surgery within 1 year after percutaneous coronary intervention with second-generation drug-eluting stents.
27 August 2022

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources